Allena Pharmaceuticals shares open 14.3 pct below IPO price in debut
Nov 2 (Reuters) - :Allena Pharmaceuticals shares open at $12 in debut on the NASDAQ versus IPO price of $14/shr.
Latest Developments forAllena Pharmaceuticals Inc
Latest Key Developments inBiotechnology
- Springworks Therapeutics Shares Open About 36.1% Above IPO Price In Debut
- Satsuma Pharmaceuticals Shares Open 26.7% Above IPO Price In Debut
- Genmab: Topline Results In Phase III Study Of Daratumumab In Combination With Carfilzomib, Dexamethasone
- Salarius Pharmaceuticals Announces Appointment Of Mark Rosenblum To Position Of Executive Vice President Finance And Interim Chief Financial Officer